RHY 4.76% 6.0¢ rhythm biosciences limited

Ann: RHY Advances Platform Expansion with Other Cancers, page-7

  1. 3,583 Posts.
    lightbulb Created with Sketch. 338
    Agilex Biolabs look solid- IMHO.

    RHY use solid partners at each stage. They make a claim that would make a pump and dump proud- but at every stage they tick all the right boxes and use reputable partners.

    A happy holder.

    IMHO DYOR
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.